| Utestående aktier | 143,653,337 shares |
| Insideraktier | 10 890 072 shares |
| Insynsägande | 7,58 % |
| Totalt antal insynspersoner | 28 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
-0.506 %( )
10949 out of 11227Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Avidity Biosciences, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Alexandria Venture Investments, LLC
10% Owner -
|
502 365 | 502 365 | |
| Carsten Boess Director - [D] | 6 692 | 6 692 | |
| Sarah Boyce President and CEO, Director - [D] [O] | 305 871 | 305 871 | |
| Todd C Brady | 0 | ||
| Charles III Calderaro Chief Technical Officer - [O] | 40 000 | 40 000 | |
|
Bihua Chen
Director, 10% Owner -
[D]
|
2 514 545 | 2 514 545 | |
| Cormorant Asset Management, LLC - | 2 514 545 | 2 514 545 | |
|
Cormorant Global Healthcare Master Fund, LP
10% Owner -
|
2 514 545 | 2 514 545 | |
|
Cormorant Private Healthcare Fund II, LP
10% Owner -
|
2 514 545 | 2 514 545 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Flanagan W. Michael Chief Scientific Officer - [O] | 80 195 | 80 195 | |
| Gallagher Kathleen P. Chief Program Officer - [O] | 50 204 | 50 204 | |
| Noreen Henig Director - [D] | 6 692 | 6 692 | |
| Steven George Hughes Chief Medical Officer - [O] | 38 867 | 38 867 | |
| Kaye Edward M. MD Director - [D] | 6 692 | 6 692 | |
| Kim Jae B. | 375 266 | ||
| Jean Jinsun Kim Director - [D] | 6 692 | 6 692 | |
| Arthur A Levin Director - [D] | 19 650 | 19 650 | |
|
Eli & Co Lilly
10% Owner -
|
2 169 396 | 2 169 396 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Michael F MacLean Chief Financial Officer - [O] | 65 806 | 65 806 | |
| Martin Michael B. | 0 | ||
| Teresa McCarthy Chief Human Resources Officer - [O] | 97 130 | 97 130 | |
| John B Moriarty Chief Legal Officer - [O] | 47 755 | 47 755 | |
| Eric Mosbrooker Chief Commercial Officer - [O] | 55 000 | 55 000 | |
|
Rtw Investments, Lp
10% Owner -
|
4 795 000 | 4 795 000 | |
| Simona Skerjanec Director - [D] | 6 692 | 6 692 | |
| Tamar Thompson Director - [D] | 6 692 | 6 692 | |
| Troy Edward Wilson Director - [D] | 68 136 | 68 136 | |
|
Roderick Wong
Director, 10% Owner -
[D]
|
4 795 000 | 4 795 000 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i RNA / Avidity Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i RNA / Avidity Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41,4095 | −15 000 | −621 | 97 130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 15 000 | 335 | 112 130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | Hughes Steven George | RNA | Common Stock | D | 45,4100 | −1 542 | −70 | 38 867 | ||||
| 2025-09-17 | 2025-09-15 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 1 542 | 10 | 40 409 | ||||
| 2025-09-12 | 2025-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 38,9351 | −20 000 | −779 | 80 195 | ||||
| 2025-09-12 | 2025-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20 000 | 284 | 100 195 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 50,0000 | −15 000 | −750 | 54 425 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 50,0000 | −14 500 | −725 | 69 425 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,4800 | 14 500 | 181 | 83 925 | ||||
| 2025-09-05 | 2025-09-05 | 4 | Boyce Sarah | RNA | Common Stock | D | 49,9487 | −50 000 | −2 497 | 305 871 | ||||
| 2025-09-05 | 2025-09-05 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 50 000 | 62 | 355 871 | ||||
| 2025-09-05 | 2025-09-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 47,0723 | −6 563 | −309 | 55 000 | ||||
| 2025-09-05 | 2025-09-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 6 563 | 59 | 61 563 | ||||
| 2025-09-02 | 2025-09-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 47,4200 | −188 | −9 | 50 204 | ||||
| 2025-08-29 | 2025-08-28 | 4 | Boyce Sarah | RNA | Common Stock | D | 49,3880 | −25 000 | −1 235 | 305 871 | ||||
| 2025-08-29 | 2025-08-28 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 25 000 | 31 | 330 871 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 46,4047 | −2 208 | −102 | 38 867 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2 208 | 22 | 41 075 | ||||
| 2025-08-15 | 2025-08-13 | 4 | Hughes Steven George | RNA | Common Stock | D | 46,6600 | −1 542 | −72 | 38 867 | ||||
| 2025-08-15 | 2025-08-13 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 1 542 | 10 | 40 409 | ||||
| 2025-08-15 | 2025-08-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 42,7264 | −30 914 | −1 321 | 65 806 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 46,5632 | −10 000 | −466 | 97 130 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 10 000 | 223 | 107 130 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 44,0626 | −6 120 | −270 | 55 000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 44,0626 | −124 687 | −5 494 | 61 120 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 124 687 | 1 128 | 185 807 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 4 | RNA | Common Stock | I | 45,0000 | −17 777 | −800 | 17 776 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 3 | RNA | Common Stock | I | 45,0000 | −17 777 | −800 | 17 776 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 1 | RNA | Common Stock | I | 45,0000 | −15 000 | −675 | 285 000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 2 | RNA | Common Stock | I | 45,0000 | −15 000 | −675 | 285 000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 45,0000 | −7 500 | −338 | 69 425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,4800 | 7 500 | 94 | 76 925 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 45,0000 | −22 000 | −990 | 69 425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,0300 | 22 000 | 265 | 91 425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 47,6175 | −107 500 | −5 119 | 19 650 | ||||
| 2025-08-08 | 2025-08-06 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,3400 | 107 500 | 2 402 | 127 150 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | −33 983 | −1 452 | 38 867 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | −17 667 | −755 | 72 850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 17 667 | 179 | 90 517 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | −6 167 | −264 | 72 850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 22,4700 | 6 167 | 139 | 79 017 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | −12 334 | −527 | 72 850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 12 334 | 81 | 85 184 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | −11 283 | −482 | 72 850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 15,9600 | 11 283 | 180 | 84 133 | ||||
| 2025-08-05 | 2025-08-04 | 4 | Moriarty John B | RNA | Common Stock | D | 36,2100 | −2 245 | −81 | 47 755 | ||||
| 2025-06-18 | 2025-06-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 30,2400 | −911 | −28 | 50 392 | ||||
| 2025-06-12 | 2025-06-10 | 4 | Henig Noreen | RNA | Common Stock | D | 6 692 | 6 692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | BOESS CARSTEN | RNA | Common Stock | D | 6 692 | 6 692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Kaye Edward M. MD | RNA | Common Stock | D | 6 692 | 6 692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 6 692 | 19 650 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Skerjanec Simona | RNA | Common Stock | D | 6 692 | 6 692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 6 692 | 69 425 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Thompson Tamar | RNA | Common Stock | D | 6 692 | 6 692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Kim Jean Jinsun | RNA | Common Stock | D | 6 692 | 6 692 | ||||||
| 2025-06-12 | 2025-06-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 32,8847 | −20 000 | −658 | 80 195 | ||||
| 2025-06-12 | 2025-06-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20 000 | 284 | 100 195 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,4822 | −5 875 | −191 | 50 554 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5 875 | 98 | 56 429 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,3956 | −5 875 | −190 | 50 554 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5 875 | 98 | 56 429 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 27,8274 | −329 | −9 | 50 554 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 329 | 5 | 50 883 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 27,8274 | −5 546 | −154 | 50 554 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 14,7000 | 5 546 | 82 | 56 100 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Hughes Steven George | RNA | Common Stock | D | 31,0598 | −9 578 | −297 | 72 850 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 31,0578 | −31 540 | −980 | 305 871 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 31,0584 | −11 780 | −366 | 80 195 | ||||
| 2025-03-21 | 2025-03-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 31,0554 | −7 935 | −246 | 96 720 | ||||
| 2025-03-21 | 2025-03-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 31,0598 | −7 778 | −242 | 97 130 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 30,1307 | −20 000 | −603 | 91 975 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20 000 | 284 | 111 975 | ||||
| 2025-03-04 | 2025-03-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 29,4140 | −5 875 | −173 | 50 554 | ||||
| 2025-03-04 | 2025-03-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 14,7000 | 5 875 | 86 | 56 429 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,1563 | −5 875 | −189 | 50 554 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5 875 | 98 | 56 429 | ||||
| 2025-01-23 | 2025-01-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 28,5987 | −1 872 | −54 | 12 958 | ||||
| 2025-01-23 | 2025-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,5932 | −1 665 | −48 | 104 655 | ||||
| 2025-01-23 | 2025-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,5929 | −1 622 | −46 | 106 320 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28,5968 | −1 221 | −35 | 104 908 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28,5931 | −1 738 | −50 | 106 129 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 28,5920 | −1 812 | −52 | 91 975 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 28,5967 | −3 860 | −110 | 93 787 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 28,5946 | −5 659 | −162 | 337 411 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 28,5932 | −4 738 | −135 | 343 070 | ||||
| 2025-01-23 | 2025-01-22 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 30,1609 | −5 629 | −170 | 50 554 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5930 | −1 817 | −52 | 56 183 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5953 | −670 | −19 | 58 000 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5900 | −1 295 | −37 | 58 670 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 28,5906 | −2 032 | −58 | 82 428 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 28,5955 | −1 915 | −55 | 84 460 | ||||
| 2025-01-08 | 2025-01-06 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25 000 | 97 647 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25 000 | 107 867 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Moriarty John B | RNA | Common Stock | D | 25 000 | 50 000 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 25 000 | 107 942 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 82 500 | 347 808 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 25 000 | 86 375 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 25 000 | 59 965 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 25 000 | 61 120 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Calderaro Charles III | RNA | Common Stock | D | 40 000 | 40 000 | ||||||
| 2025-01-08 | 3 | Mosbrooker Eric | RNA | Common Stock | D | 36 120 | ||||||||
| 2025-01-08 | 3 | Gallagher Kathleen P. | RNA | Common Stock | D | 34 965 | ||||||||
| 2025-01-08 | 3 | Hughes Steven George | RNA | Common Stock | D | 61 375 | ||||||||
| 2024-12-19 | 2024-12-18 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 32,6600 | −12 742 | −416 | 72 647 | ||||
| 2024-12-19 | 2024-12-18 | 4 | Boyce Sarah | RNA | Common Stock | D | 32,6600 | −31 855 | −1 040 | 265 308 | ||||
| 2024-12-19 | 2024-12-18 | 4 | MacLean Michael F | RNA | Common Stock | D | 32,6600 | −11 151 | −364 | 82 942 | ||||
| 2024-12-19 | 2024-12-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 32,6600 | −11 151 | −364 | 82 867 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 33,2642 | −25 000 | −832 | 94 018 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25 000 | 356 | 119 018 | ||||
| 2024-12-13 | 2024-12-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 35,7667 | −24 000 | −858 | 85 389 | ||||
| 2024-12-13 | 2024-12-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 22,4700 | 24 000 | 539 | 109 389 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41,1408 | −25 000 | −1 029 | 94 018 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25 000 | 356 | 119 018 | ||||
| 2024-11-20 | 2024-11-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 42,1224 | −3 323 | −140 | 14 830 | ||||
| 2024-11-20 | 2024-11-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 3 323 | 4 | 18 153 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 45,3339 | −13 875 | −629 | 94 093 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 6,5700 | 13 875 | 91 | 107 968 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 45,3339 | −65 182 | −2 955 | 94 093 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 65 182 | 575 | 159 275 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 46,2188 | −27 262 | −1 260 | 94 093 | ||||
| 2024-10-23 | 2024-10-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 46,6335 | −5 000 | −233 | 14 830 | ||||
| 2024-10-23 | 2024-10-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 48,5204 | −25 000 | −1 213 | 94 018 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25 000 | 356 | 119 018 | ||||
| 2024-10-09 | 2024-10-07 | 4 | Thompson Tamar | RNA | Common Stock | D | 44,9753 | −30 000 | −1 349 | 0 | ||||
| 2024-10-09 | 2024-10-07 | 4 | Thompson Tamar | RNA | Common Stock | D | 27,6300 | 30 000 | 829 | 30 000 | ||||
| 2024-10-03 | 2024-10-01 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 47,6178 | −62 500 | −2 976 | 85 389 | ||||
| 2024-10-03 | 2024-10-01 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 26,7500 | 62 500 | 1 672 | 147 889 | ||||
| 2024-09-23 | 2024-09-23 | 4 | McCarthy Teresa | RNA | Common Stock | D | 44,0004 | −13 153 | −579 | 69 018 | ||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25 000 | 94 018 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25 000 | 94 018 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 43,8926 | −11 847 | −520 | 85 389 | ||||
| 2024-09-23 | 2024-09-23 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 44,0004 | −13 153 | −579 | 72 718 | ||||
| 2024-09-23 | 2024-09-19 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25 000 | 97 718 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25 000 | 97 718 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | Boyce Sarah | RNA | Common Stock | D | 44,0001 | −32 880 | −1 447 | 234 663 | ||||
| 2024-09-23 | 2024-09-19 | 4 | Boyce Sarah | RNA | Common Stock | D | 62 500 | 297 163 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | Boyce Sarah | RNA | Common Stock | D | 62 500 | 297 163 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | MacLean Michael F | RNA | Common Stock | D | 44,0000 | −11 510 | −506 | 96 355 | ||||
| 2024-09-23 | 2024-09-19 | 4 | MacLean Michael F | RNA | Common Stock | D | 25 000 | 121 355 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | MacLean Michael F | RNA | Common Stock | D | 25 000 | 121 355 | ||||||
| 2024-09-20 | 2024-09-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,7316 | −5 000 | −229 | 14 830 | ||||
| 2024-09-20 | 2024-09-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,3972 | −14 894 | −602 | 60 871 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,3987 | −34 000 | −1 374 | 75 765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 22,4700 | 34 000 | 764 | 109 765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,4002 | −62 500 | −2 525 | 75 765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 26,7500 | 62 500 | 1 672 | 138 265 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 40,4017 | −25 000 | −1 010 | 57 171 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25 000 | 356 | 82 171 | ||||
| 2024-09-10 | 2024-09-06 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 22 500 | 22 500 | ||||||
| 2024-09-10 | 2024-09-06 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | −22 500 | 131 372 | ||||||
| 2024-08-21 | 2024-08-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,1893 | −5 000 | −226 | 14 830 | ||||
| 2024-08-21 | 2024-08-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-08-07 | 2024-08-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 43,3508 | −28 000 | −1 214 | 205 043 | ||||
| 2024-08-07 | 2024-08-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28 000 | 35 | 233 043 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Moriarty John B | RNA | Common Stock | D | 25 000 | 25 000 | ||||||
| 2024-07-23 | 2024-07-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,0138 | −5 000 | −225 | 14 830 | ||||
| 2024-07-23 | 2024-07-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-07-11 | 2024-07-09 | 4 | Boyce Sarah | RNA | Common Stock | D | 39,9315 | −28 000 | −1 118 | 205 043 | ||||
| 2024-07-11 | 2024-07-09 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28 000 | 35 | 233 043 | ||||
| 2024-06-21 | 2024-06-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 37,5901 | −5 000 | −188 | 14 830 | ||||
| 2024-06-21 | 2024-06-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-06-20 | 2024-06-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 39,1294 | −9 864 | −386 | 32 171 | ||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25 000 | 57 171 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25 000 | 57 171 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | Boyce Sarah | RNA | Common Stock | D | 39,1295 | −32 074 | −1 255 | 142 543 | ||||
| 2024-06-20 | 2024-06-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 62 500 | 205 043 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 62 500 | 205 043 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | MacLean Michael F | RNA | Common Stock | D | 39,1294 | −11 228 | −439 | 57 865 | ||||
| 2024-06-20 | 2024-06-17 | 4 | MacLean Michael F | RNA | Common Stock | D | 25 000 | 82 865 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | MacLean Michael F | RNA | Common Stock | D | 25 000 | 82 865 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 39,1297 | −10 106 | −395 | 50 765 | ||||
| 2024-06-20 | 2024-06-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25 000 | 75 765 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25 000 | 75 765 | ||||||
| 2024-06-14 | 2024-06-12 | 4 | MacLean Michael F | RNA | Common Stock | D | 35,7153 | −104 245 | −3 723 | 44 093 | ||||
| 2024-06-14 | 2024-06-12 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 104 245 | 919 | 148 338 | ||||
| 2024-06-14 | 2024-06-13 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 40,0797 | −60 000 | −2 405 | 153 872 | ||||
| 2024-06-14 | 2024-06-12 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 35,0657 | −40 000 | −1 403 | 213 872 | ||||
| 2024-06-14 | 2024-06-14 | 4 | Boyce Sarah | RNA | Common Stock | D | 40,0784 | −35 767 | −1 433 | 112 117 | ||||
| 2024-06-14 | 2024-06-14 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 35 767 | 44 | 147 884 | ||||
| 2024-06-14 | 2024-06-13 | 4 | Boyce Sarah | RNA | Common Stock | D | 40,0760 | −164 233 | −6 582 | 112 117 | ||||
| 2024-06-14 | 2024-06-13 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 164 233 | 204 | 276 350 | ||||
| 2024-06-14 | 2024-06-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 35,7302 | −100 000 | −3 573 | 112 117 | ||||
| 2024-06-14 | 2024-06-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 100 000 | 124 | 212 117 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Boyce Sarah | RNA | Common Stock | D | 27,4207 | −28 000 | −768 | 112 117 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28 000 | 35 | 140 117 | ||||
| 2024-05-21 | 2024-05-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 29,8962 | −5 000 | −149 | 14 830 | ||||
| 2024-05-21 | 2024-05-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-05-16 | 2024-05-14 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,2806 | −75 000 | −2 121 | 44 093 | ||||
| 2024-05-16 | 2024-05-14 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 75 000 | 662 | 119 093 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 25,5375 | −28 000 | −715 | 112 117 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28 000 | 35 | 140 117 | ||||
| 2024-04-22 | 2024-04-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,8246 | −5 000 | −114 | 14 830 | ||||
| 2024-04-22 | 2024-04-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-04-03 | 2024-04-03 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 27,1107 | −20 000 | −542 | 253 872 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 26,2471 | −28 000 | −735 | 112 117 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28 000 | 35 | 140 117 | ||||
| 2024-03-21 | 2024-03-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 23,9695 | −5 000 | −120 | 14 830 | ||||
| 2024-03-21 | 2024-03-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5 000 | 6 | 19 830 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacLean Michael F | RNA | Common Stock | D | 24,5190 | −40 000 | −981 | 44 093 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 40 000 | 353 | 84 093 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0000 | −2 641 | −58 | 14 830 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0366 | −25 000 | −551 | 17 471 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 25 000 | 31 | 42 471 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,6315 | −28 000 | −634 | 112 117 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28 000 | 35 | 140 117 | ||||
| 2024-03-12 | 2024-03-08 | 4 | Boyce Sarah | RNA | Common Stock | D | 21,3894 | −84 000 | −1 797 | 112 117 | ||||
| 2024-03-12 | 2024-03-08 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 84 000 | 104 | 196 117 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 20,1346 | −84 000 | −1 691 | 112 117 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 84 000 | 104 | 196 117 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Boyce Sarah | RNA | Common Stock | D | 10,1300 | −5 092 | −52 | 44 008 | ||||
| 2024-01-23 | 2024-01-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 62 500 | 67 209 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 10,1300 | −1 859 | −19 | 17 471 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 10,1300 | −4 129 | −42 | 35 871 | ||||
| 2024-01-23 | 2024-01-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 20 000 | 20 290 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | McCarthy Teresa | RNA | Common Stock | D | 10,1300 | −2 065 | −21 | 17 035 | ||||
| 2024-01-23 | 2024-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 16 500 | 17 458 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | MacLean Michael F | RNA | Common Stock | D | 10,1300 | −1 616 | −16 | 16 884 | ||||
| 2024-01-23 | 2024-01-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 22 500 | 27 209 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By trust FBO Children 3 and 4 | RNA | Common Stock | I | 250 000 | 300 000 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | −250 000 | 13 711 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By trust FBO Children 1 and 2 | RNA | Common Stock | I | 300 000 | 300 000 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | −300 000 | 263 711 | ||||||
| 2023-03-17 | 2023-03-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0100 | −100 | −2 | 19 330 | ||||
| 2023-03-17 | 2023-03-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 100 | 0 | 19 430 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 24,2381 | −523 | −13 | 19 330 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 23,6246 | −9 477 | −224 | 19 853 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 10 000 | 12 | 29 330 | ||||
| 2023-02-03 | 2023-02-03 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,2600 | −3 221 | −78 | 53 352 | ||||
| 2023-02-03 | 2023-02-03 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 3 221 | 4 | 56 573 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,3628 | −45 879 | −1 118 | 53 352 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 45 879 | 57 | 99 231 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,2716 | −900 | −22 | 53 352 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 900 | 1 | 54 252 | ||||
| 2023-01-24 | 2023-01-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 50 000 | 53 352 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40 000 | 40 290 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 18 000 | 19 330 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 18 500 | 21 852 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 20 000 | 20 958 | ||||||
| 2023-01-17 | 2023-01-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0028 | −10 000 | −220 | 1 330 | ||||
| 2023-01-17 | 2023-01-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 10 000 | 12 | 11 330 | ||||
| 2023-01-03 | 2022-12-29 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0142 | −40 000 | −881 | 1 330 | ||||
| 2023-01-03 | 2022-12-29 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 40 000 | 50 | 41 330 | ||||
| 2022-08-31 | 2022-08-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0798 | −3 499 | −77 | 1 330 | ||||
| 2022-08-31 | 2022-08-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 3 499 | 4 | 4 829 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,1182 | −62 498 | −1 382 | 1 330 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 34 758 | 43 | 63 828 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 27 740 | 15 | 29 070 | ||||
| 2022-08-31 | 2022-08-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0000 | −14 003 | −308 | 1 330 | ||||
| 2022-08-31 | 2022-08-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 14 003 | 7 | 15 333 | ||||
| 2022-08-26 | 2022-08-25 | 4 | Boyce Sarah | RNA | Common Stock | D | 23,0690 | −14 855 | −343 | 0 | ||||
| 2022-08-26 | 2022-08-25 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 14 855 | 18 | 14 855 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,7971 | −35 045 | −799 | 0 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 35 045 | 43 | 35 045 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,4700 | −100 | −2 | 0 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 100 | 0 | 100 | ||||
| 2022-03-15 | 2022-01-21 | 4 | McCarthy Teresa | RNA | Stock Option (Right to Buy) | D | 14,22 | 157 500 | 157 500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | Flanagan W. Michael | RNA | Stock Option (Right to Buy) | D | 14,22 | 136 500 | 136 500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | MacLean Michael F | RNA | Stock Option (Right to Buy) | D | 14,22 | 131 250 | 131 250 | |||||
| 2022-03-15 | 2022-01-21 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 14,22 | 115 500 | 115 500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | Boyce Sarah | RNA | Stock Option (Right to Buy) | D | 14,22 | 425 000 | 425 000 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | −604 | 41 743 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | −24 396 | 166 770 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,8887 | −25 000 | −697 | 1 330 | ||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 604 | 0 | 26 330 | ||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 24 396 | 30 | 25 726 | ||||
| 2021-08-27 | 2021-08-25 | 4 | Mosbrooker Eric | RNA | Stock Option (Right to Buy) | D | 20,83 | 30 000 | 30 000 | |||||
| 2021-08-06 | 2021-08-04 | 4 | RTW INVESTMENTS, LP By RTW | RNA | Common Stock | I | 18,0000 | 800 000 | 14 400 | 4 795 000 | ||||
| 2021-08-06 | 2020-06-11 | 4 | RTW INVESTMENTS, LP By RTW | RNA | Series C Preferred Stock | I | −3 995 000 | 0 | ||||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | −3 083 | 42 347 | |||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | −17 017 | 191 166 | |||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 29,1398 | −2 647 | −77 | 1 330 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,9703 | −17 453 | −488 | 3 977 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 3 083 | 2 | 21 430 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 17 017 | 21 | 18 347 | ||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | −100 | 208 183 | |||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,7550 | −100 | −3 | 1 330 | ||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 100 | 0 | 1 430 | ||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | −200 | 208 283 | |||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,7500 | −200 | −6 | 1 330 | ||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 200 | 0 | 1 530 | ||||
| 2021-06-17 | 2021-06-16 | 4 | WONG RODERICK | RNA | Stock Option (Right to Buy) | D | 26,09 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 26,0249 | −23 019 | −599 | 0 | ||||
| 2021-06-16 | 2021-06-14 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 25,9174 | −14 003 | −363 | 23 019 | ||||
| 2021-06-16 | 2021-06-16 | 4 | WILSON TROY EDWARD | RNA | Stock Option (Right to Buy) | D | 26,09 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | Kaye Edward M. MD | RNA | Stock Option (Right to Buy) | D | 26,09 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | Henig Noreen | RNA | Stock Option (Right to Buy) | D | 26,09 | 15 000 | 15 000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | BOESS CARSTEN | RNA | Stock Option (Right to Buy) | D | 26,09 | 15 000 | 15 000 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | −1 975 | 45 430 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | −2 625 | 208 483 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,8655 | −4 600 | −128 | 0 | ||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 1 975 | 1 | 4 600 | ||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 2 625 | 3 | 2 625 | ||||
| 2021-03-18 | 2021-03-05 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 37 022 | 37 022 | ||||||
| 2021-03-18 | 2021-03-05 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | −37 022 | 273 872 | ||||||
| 2021-02-04 | 2021-02-02 | 4 | Boyce Sarah | RNA | Stock Option (Right to Buy) | D | 22,34 | 300 000 | 300 000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | MacLean Michael F | RNA | Stock Option (Right to Buy) | D | 22,34 | 92 000 | 92 000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 22,34 | 120 000 | 120 000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Kim Jae B. | RNA | Stock Option (Right to Buy) | D | 22,34 | 82 000 | 82 000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Baroldi Joseph | RNA | Stock Option (Right to Buy) | D | 22,34 | 87 000 | 87 000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Flanagan W. Michael | RNA | Stock Option (Right to Buy) | D | 26,75 | 150 000 | 150 000 | |||||
| 2021-01-11 | 2021-01-11 | 4 | Kim Jean Jinsun | RNA | Stock Option (Right to Buy) | D | 27,63 | 30 000 | 30 000 | |||||
| 2021-01-11 | 2021-01-11 | 4 | Thompson Tamar | RNA | Stock Option (Right to Buy) | D | 27,63 | 30 000 | 30 000 | |||||
| 2020-12-28 | 2020-12-22 | 4 | WILSON TROY EDWARD By family trust 2 | RNA | Common Stock | I | 100 000 | 100 000 | ||||||
| 2020-12-28 | 2020-12-22 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | −100 000 | 89 618 | ||||||
| 2020-07-27 | 2020-07-27 | 4 | Kim Jae B. | RNA | Stock Option (Right to Buy) | D | 25,05 | 375 266 | 375 266 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC | RNA | Series C Convertible Preferred Stock | D | 2 214 545 | 0 | ||||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC See Footnotes | RNA | Common Stock | I | 18,0000 | 300 000 | 5 400 | 2 514 545 | ||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC See Footnotes | RNA | Common Stock | I | 2 214 545 | 2 214 545 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LILLY ELI & CO | RNA | Series C Preferred Stock | D | −4 576 342 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LILLY ELI & CO | RNA | Common Stock | D | 2 169 396 | 2 169 396 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series C convertible preferred stock | D | −134 126 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series B convertible preferred stock | D | −530 616 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series A convertible preferred stock | D | −395 000 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Common stock | D | 502 365 | 502 365 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LEVIN ARTHUR A By family trust | RNA | Series A Preferred Stock | I | −35 337 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 16 751 | 310 894 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Series C Preferred Stock | I | −6 423 431 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Common Stock | I | 18,0000 | 950 000 | 17 100 | 3 995 000 | ||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Common Stock | I | 3 045 000 | 3 045 000 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series C Preferred Stock | I | −108 504 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series B Preferred Stock | I | −35 374 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series A Preferred Stock | I | −254 907 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 189 042 | 805 301 | ||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1 090 303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912 536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912 536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936 238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936 238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1 516 944 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1 090 303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936 238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936 238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1 090 303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1 516 944 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936 238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936 238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912 536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912 536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912 536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912 536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1 516 944 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588 286 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588 286 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588 286 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
